105. Dopa-responsive dystonia: guanosine triphosphate cyclohydrolase 1, tyrosine hydroxylase, and sepiapterin reductase

Article type: Letter to Editor                                                                                    

Article title: Dopa-responsive dystonia: guanosine triphosphate cyclohydrolase 1, tyrosine hydroxylase, and sepiapterin reductase

 

Journal: Ibnosina Journal of Medicine and Biomedical Sciences

Year: 2021

Authors: Jamir Pitton Rissardo, Ana Letícia Fornari Caprara

E-mail: jamirrissardo@gmail.com

 

ABSTRACT

DRD is a very rare (1 in 1 million people) inherited type of dystonia that typically begins during childhood but may begin in adolescence or adulthood. DRD may be caused by the mutations in the guanosine triphosphate cyclohydrolase 1, tyrosine hydroxylase (TH), SPR genes, or the cause may be unknown. These genes are related to the enzymes that are associated with a common pathway responsible for the production of dopamine and serotonin (TH is not related). The deficiency of dopamine can lead to a disbalance on the nigrostriatal area leading to dystonia and  Parkinsonism More Details, mainly in the lower limbs, where the most common clinical manifestation is tip-toe walking. A special type of DRD is the Segawa disease (DYT5 dystonia), which is dopa-responsive generalized dystonia, caused by abnormalities of the gene GCH-1 located on chromosomes 14q22.1–q22.2.

Keywords: Dopa-responsive dystonia, sepiapterin reductase, tyrosine hydroxylase

 

Full text available at:

https://www.ijmbs.org/article.asp?issn=1947-489X;year=2021;volume=13;issue=1;spage=44;epage=45;aulast=Pitton

 

DOI

10.4103/ijmbs.ijmbs_23_21

 

Citation

Rissardo JP, Caprara AL. Dopa-responsive dystonia: guanosine triphosphate cyclohydrolase 1, tyrosine hydroxylase, and sepiapterin reductase. Ibnosina J Med Biomed Sci 2021;13:44-5